Omada Health CFO sells 35,600 shares after option exercise
Omada Health, Inc. Chief Financial Officer Steven L. Cook reported an exercise-and-sale transaction involving 35,600 shares of common stock.
Rhea-AI Filing Summary
Omada Health, Inc. Chief Financial Officer Steven L. Cook reported an exercise-and-sale transaction involving 35,600 shares of common stock. On July 1 and July 7, 2026, he exercised stock options covering 35,600 shares at exercise prices of $7.68, $8.01 and $8.28 per share and sold the same number of shares in open-market trades.
The reported sales were 23,263 shares at a weighted average price of $22.7615 per share and 12,337 shares at a weighted average price of $23.0883 per share. Following the transactions, Cook directly holds 187,209 shares of Omada Health common stock. The filing notes that at least one sale was made under a Rule 10b5-1 trading plan adopted on March 14, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 35,600 shares ($520K approx. pre-tax spread)
Exercise and Sale
10 txns
Insider
Cook Steven L.
Role
Chief Financial Officer
Sold
35,600 shs ($814K)
Approx. gross sale proceeds
$814K
Approx. exercise cost
$294K
Approx. pre-tax spread
$520K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 10,601 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) | 1,042 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) | 694 | $0.00 | $0.00 |
| Exercise | Common Stock | 10,601 | $8.28 | $88K |
| Exercise | Common Stock | 1,042 | $8.01 | $8K |
| Exercise | Common Stock | 694 | $7.68 | $5K |
| Sale | Common Stock | 12,337 | $23.0883 | $285K |
| Exercise | Stock Option (Right to Buy) | 23,263 | $0.00 | $0.00 |
| Exercise | Common Stock | 23,263 | $8.28 | $193K |
| Sale | Common Stock | 23,263 | $22.7615 | $530K |
Holdings After Transaction:
Stock Option (Right to Buy) — 308,965 contracts (Direct);
Common Stock — 187,209 shares (Direct)
Footnotes (6)
- F1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026.
- F2. This transaction was executed in multiple trades at prices ranging from $22.11 to $23.09. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3. This transaction was executed in multiple trades at prices ranging from $23.00 to $23.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4. 100% of the shares subject to the option are fully vested and exercisable.
- F5. 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 1, 2024 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
- F6. 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 1, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
Key Figures
Shares sold: 35,600 shares
First sale volume and price: 23,263 shares at $22.7615
Second sale volume and price: 12,337 shares at $23.0883
+4 more
7 metrics
Shares sold
35,600 shares
Total Omada Health common shares sold by CFO in July 2026
First sale volume and price
23,263 shares at $22.7615
Weighted average sale price on July 1, 2026
Second sale volume and price
12,337 shares at $23.0883
Weighted average sale price on July 7, 2026
Options exercised
35,600 shares
Total shares acquired via stock option exercises
Exercise prices
$7.68, $8.01, $8.28 per share
Strike prices for Omada Health stock options exercised
Post-transaction holdings
187,209 shares
CFO’s direct Omada Health common stock after transactions
10b5-1 plan adoption date
March 14, 2026
Date CFO adopted Rule 10b5-1 trading plan
Key Terms
Rule 10b5-1 trading plan, Stock Option (Right to Buy), weighted average price, vesting commencement date, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy) with underlying security title Common Stock."
weighted average price financial
"This transaction was executed in multiple trades at prices ranging from $22.11 to $23.09. The price reported above reflects the weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
vesting commencement date financial
"1/48th of the shares subject to the option vest on each monthly anniversary measured from February 1, 2024 (the "Vesting Commencement Date")."
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
expiration date financial
"expiration_date: 2035-01-27T00:00:00.000Z for options with a $7.68 exercise price."
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Omada Health (OMDA) CFO Steven L. Cook report?
Steven L. Cook reported exercising options for 35,600 Omada Health shares and selling the same number in open-market trades. These transactions combined option exercises at lower strike prices with sales at market prices above $22 per share.
Did Omada Health (OMDA) CFO’s Form 4 involve stock option exercises?
Yes. The filing shows exercises of stock options for 35,600 Omada Health shares at exercise prices of $7.68, $8.01 and $8.28 per share. The exercised options converted into common stock, which was then sold in the market.
Were Omada Health (OMDA) CFO’s stock sales under a Rule 10b5-1 plan?
At least one reported transaction was made under a Rule 10b5-1 trading plan adopted on March 14, 2026. Such pre-arranged plans allow insiders to schedule trades in advance, helping separate routine diversification from discretionary market-timing decisions.
What do the weighted average prices mean in the Omada Health (OMDA) Form 4?
The filing states that some transactions occurred in multiple trades within price ranges, so it reports weighted average prices. For example, sales ranged from $22.11 to $23.09, with the average price of $23.0883 summarizing the blended execution level across trades.
AI-generated analysis. How Rhea-AI works. Not financial advice.
